Publication

Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    David S. Hui, Chinese University of Hong KongEsam I. Azhar, King Abdulaziz UniversityYae-Jean Kim, Sungkyunkwan UniversityZiad Memish, Emory UniversityMyoung-don Oh, Seoul National UniversityAlimuddin Zumla, University College London
Language
  • English
Date
  • 2018-08-01
Publisher
  • Elsevier
Publication Version
Copyright Statement
  • © 2018 Elsevier Ltd. All rights reserved.
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 18
Issue
  • 8
Start Page
  • e217
End Page
  • e227
Grant/Funding Information
  • AZ acknowledges support from the National Institute of Health and Research (NIHR) Biomedical Research Centre at University College London Hospitals (UK) and is in receipt of an NIHR Senior Investigator award.
Supplemental Material (URL)
Abstract
  • Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonosis that causes death in 35·7% of cases. As of Feb 28, 2018, 2182 cases of MERS-CoV infection (with 779 deaths) in 27 countries were reported to WHO worldwide, with most being reported in Saudi Arabia (1807 cases with 705 deaths). MERS-CoV features prominently in the WHO blueprint list of priority pathogens that threaten global health security. Although primary transmission of MERS-CoV to human beings is linked to exposure to dromedary camels (Camelus dromedarius), the exact mode by which MERS-CoV infection is acquired remains undefined. Up to 50% of MERS-CoV cases in Saudi Arabia have been classified as secondary, occurring from human-to-human transmission through contact with asymptomatic or symptomatic individuals infected with MERS-CoV. Hospital outbreaks of MERS-CoV are a hallmark of MERS-CoV infection. The clinical features associated with MERS-CoV infection are not MERS-specific and are similar to other respiratory tract infections. Thus, the diagnosis of MERS can easily be missed, unless the doctor or health-care worker has a high degree of clinical awareness and the patient undergoes specific testing for MERS-CoV. The largest outbreak of MERS-CoV outside the Arabian Peninsula occurred in South Korea in May, 2015, resulting in 186 cases with 38 deaths. This outbreak was caused by a traveller with undiagnosed MERS-CoV infection who became ill after returning to Seoul from a trip to the Middle East. The traveller visited several health facilities in South Korea, transmitting the virus to many other individuals long before a diagnosis was made. With 10 million pilgrims visiting Saudi Arabia each year from 182 countries, watchful surveillance by public health systems, and a high degree of clinical awareness of the possibility of MERS-CoV infection is essential. In this Review, we provide a comprehensive update and synthesis of the latest available data on the epidemiology, determinants, and risk factors of primary, household, and nosocomial transmission of MERS-CoV, and suggest measures to reduce risk of transmission.
Author Notes
  • Correspondence: Prof Sir Alimuddin Zumla, Centre for Clinical Microbiology, UCL Division of Infection and Immunity, University College London Hospitals NHS Foundation Trust, London WC1E 6BT, UK, a.zumla@ucl.ac.uk
Keywords
Research Categories
  • Health Sciences, Health Care Management
  • Health Sciences, Epidemiology
  • Health Sciences, Occupational Health and Safety
  • Health Sciences, Public Health

Tools

Relations

In Collection:

Items